Morgan Stanley Says Indian Drugmakers Need To Get Into Speciality, Biosimilars Segments
Purple pills sit in a container. (Photographer: Daniel Acker/Bloomberg)

Morgan Stanley Says Indian Drugmakers Need To Get Into Speciality, Biosimilars Segments

Bookmark
Indian pharmaceutical companies’ future growth is dependent on how soon they venture into the specialty drugs and biosimilars business, according to Morgan Stanley Analyst Sameer Baisiwala.“Special...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.